Gravidas Diagnostics, Inc.

Gravidas is developing a rapid PoC test to identify pregnant women at risk of developing severe or life-threatening preeclampsia. Founded and managed by practicing clinical and scientific leaders in assay development and pregnancy and preeclampsia, Gravidas is at an advanced stage of product development. There is a significant unmet medical for a simple test for determining who is at risk for developing severe preeclampsia due to the current low-confidence diagnosis of pregnant women presenting with preeclamptic symptoms. Without such a test, there may be mistimed or unnecessary medical intervention, leading to rapid progression to severe disease and pregnancy/delivery complications. Preeclampsia is the leading cause of maternal and fetal mortality and morbidity worldwide, resulting in a large addressable market in the U.S. and around the world for such a test.